Related Experiment Video
Updated: May 16, 2025

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
A global epidemic serotype 14 Streptococcus pneumoniae switching to non-vaccine types
Jinglin Yue1,2, Lei Chen3, Tingzhu Yao1,2
1Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Insights
Pneumococcal conjugate vaccines (PCV) reduce vaccine-type bacteria, but non-vaccine types (NVT) increase. A serotype switch from 14 to 15B in a prevalent strain shows adaptive evolution, potentially leading to future pandemics.
Area of Science:
- Microbiology
- Genomics
- Epidemiology
Background:
- Streptococcus pneumoniae causes pneumonia globally, with vaccine-type strains decreasing post-PCV introduction.
- Non-vaccine-type (NVT) S. pneumoniae strains have increased, particularly in nasopharyngeal carriage and disease incidence.
- Serotype switching, involving alterations in the cps gene locus, is a key concern for vaccine effectiveness.
Purpose of the Study:
- To analyze S. pneumoniae clinical isolates for serotype distribution and evaluate vaccine effectiveness.
- To identify multidrug-resistant NVT S. pneumoniae, focusing on the CC876 complex and serotype 14 clones.
- To investigate a potential serotype switch event from serotype 14 to 15B in a prevalent ST4749 strain.
Main Methods:
- High-throughput sequencing of 166 S. pneumoniae clinical isolates from Xiamen Children's Hospital, China.
- Serotyping of isolates to assess vaccine type prevalence and identify NVT strains.
- Genomic analysis to map recombination sites and identify genetic elements involved in serotype switching.
Main Results:
- A significant increase in NVT S. pneumoniae prevalence was observed, correlating with PCV introduction.
- Identification of multidrug-resistant NVT S. pneumoniae within the epidemic CC876 complex.
- Discovery of a serotype 15B/ST4749 strain, likely resulting from a serotype switch from serotype 14/ST4749, involving the cps locus and comC.
Conclusions:
- The study highlights the adaptive evolution of S. pneumoniae under vaccination pressure, evidenced by serotype switching.
- The identified novel NVT strain (15B/ST4749) demonstrates potential for future pandemic emergence.
- Findings offer insights for optimizing S. pneumoniae prevention, control strategies, and vaccine deployment.
Abstract:
Streptococcus pneumoniae infection is a leading cause of bacterial pneumonia worldwide, contributing to both invasive pneumococcal diseases and non-invasive diseases. Following the introduction of pneumococcal conjugate vaccines (PCV7, PCV10, and PCV13), a significant decrease in the prevalence of vaccine-type pneumococci has been observed, while the prevalence of non-vaccine-type (NVT) pneumococci has increased. This shift has been evident in both disease incidence and nasopharyngeal carriage. Serotype switching refers to the alteration or exchange of the serotype-related cps gene locus that has been flagged globally as serotypes of concern. In this study, we collected 166 S. pneumoniae clinical isolates and analyzed the serotypes of isolates to evaluate vaccine effectiveness. Additionally, we identified multidrug-resistant NVT S. pneumoniae isolates that recently emerged within the epidemic CC876 complex, a pandemic serotype 14 clone. More importantly, we identified a serotype 15B/ST4749 strain, which might have been generated through a serotype-switch event from serotype 14/ST4749. Mapping the genomic recombination sites within the serotype 15B/ST4749 progeny revealed a donated fragment encompassing cps, pbp1a, and additional key factors, including the DNA uptake-related gene comC. More importantly, as a strain that is already prevalent, the novel NVT strain possesses the potential to become a global pandemic strain.IMPORTANCEThe study employed high-throughput sequencing to analyze Streptococcus pneumoniae isolates from Xiamen Children's Hospital, China, to evaluate vaccine effectiveness in light of serotype changes and documented the occurrence of a serotype switch (from 14 to 15B) between vaccine-type and non-vaccine-type serotypes in the ST4749 strain. This observation indicates a genomic recombination and adaptive response of S. pneumoniae under selective pressure exerted by vaccination, offering novel insights into strategies for the prevention and control of S. pneumoniae and the optimization of vaccine deployment.
Related Concept Videos
Viral Mutations
Lysogenic Cycle of Bacteriophages
Viral Recombination
Cross-reactivity

